Improving Clinical Trial Diversity Is Critical to Health Equity
Clinical trial diversity helps to ensure we have medications that are suited to reflect and treat the intended treatment population. That’s why our entire industry came together to develop and voluntarily adopt principles on closing the diversity gaps.
Understanding the challenges of the past are helping us improve the future. See how we’re taking action.
As we endeavor to push forward to change the future, we must first understand the past. Colonization, slavery, segregation, systemic racism—these experiences continue to disproportionately impact underserved communities and have created a foundation of mistrust rooted in history.
*This publication offers a limited number of free article views per month and then requires a subscription
Here is a small sampling of formative events in U.S. history that have shaped the relationship communities of color have with medical research and the health care system. This list is by no means exhaustive, but we hope it helps pave the way for candid dialogue that guides our work on equity.
Gynecological Experimentation on Enslaved Women
Closing of Medical Schools and Exclusion of Future Health Providers
Birth Control Experimentation in Puerto Rico
The Tuskegee Syphilis Study
Slavery (1619 - 1865)
Gynecological Experimentation On Enslaved Women (1845 - 1849)
Closing Of Medical Schools and Exclusion Of Future Health Providers (1870)
Birth Control Experimentation in Puerto Rico (1930s - 1970s)
The Tuskegee Syphilis Study (1932 - 1972)
Henrietta Lacks (1951)
Radioactive iodine (1956 - 1957)
What We Do Matters; How We Do It Is Equally Important
A conversation on why a community-centric approach is needed to build trust, increase awareness, enhance clinical trial diversity and advance health equity.